AstraZeneca Pharma India Limited Stock Price

BSE:506820 Community·₹172.5b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Author Program NEW Create Narrative

506820 Share Price Performance

₹0

-8984.60 (-100.00%)

₹0

-8984.60 (-100.00%)

₹0

Thu, 10 Sep 26

Share Pricen/a

506820 Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

No trending discussion available.

Snowflake Analysis

Adequate balance sheet with questionable track record.

1 Risk

0 Rewards

View Full Analysis

AstraZeneca Pharma India Limited Key Details

Last Reported Earnings

Jun 30, 2026

Next Reporting Earnings

n/a

: 67.85
: 36.83%
: 6.97%
: 12.7%

View Full Analysis

About 506820

Founded: 1979
Employees: 760
CEO: Praveen Akkinepally
WebsiteView website: www.astrazeneca.in

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cancers, including pancreatic cancer, certain blood cancers, and cancers within breast, lung, ovary, and prostate; rare diseases; and cardiovascular, renal and metabolism, and respiratory and immunology, as well as diabetes. The company serves distributors, hospitals, and government institutions. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.